ADLARITY FDA approval date

The FDA approved ADLARITY on 11 Mar 2022.

FDA approval date
11 Mar 2022

Drug identity has not yet been verified against registry records

Also recorded as DONEPEZIL HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-03-11DayADLARITYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212304", "applicant_as_listed_by_fda": "CORIUM", "brand_names": ["ADLARITY"], "active_ingredients": ["DONEPEZIL HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220311", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026